Related references
Note: Only part of the references are listed.Prediction of Propofol Clearance in Children from an Allometric Model Developed in Rats, Children and Adults versus a 0.75 Fixed-Exponent Allometric Model
Mariska Y. M. Peeters et al.
CLINICAL PHARMACOKINETICS (2010)
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0
Caroline Bazzoli et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Ontogeny of midazolam glucuronidation in preterm infants
Saskia N. de Wildt et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Theoretical Versus Empirical Allometry: Facts Behind Theories and Application to Pharmacokinetics
Iftekhar Mahmood
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Curvature in metabolic scaling
Tom Kolokotrones et al.
NATURE (2010)
Extended-interval gentamicin: Population pharmacokinetics in pediatric critical illness
Sara Arenas Lopez et al.
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Once-Daily Gentamicin Dosing in Pediatric Patients Without Cystic Fibrosis
Erin J. McDade et al.
PHARMACOTHERAPY (2010)
Once-Daily Gentamicin Dosing in Children with Febrile Neutropenia Resulting from Antineoplastic Therapy
Miriam Inparajah et al.
PHARMACOTHERAPY (2010)
Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
Radojka M. Savic et al.
AAPS JOURNAL (2009)
Population pharmacokinetics of the two enantiomers of tramadol and O-demethyl tramadol after surgery in children
F. Bressolle et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Morphine Glucuronidation in Preterm Neonates, Infants and Children Younger than 3 Years
Catherijne A. J. Knibbe et al.
CLINICAL PHARMACOKINETICS (2009)
Tailor-made drug treatment for children Creation of an infrastructure for data-sharing and population PK-PD modeling
Ibrahim Ince et al.
DRUG DISCOVERY TODAY (2009)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis
Catherine M. T. Sherwin et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
The problems in scaling adult drug doses to children
T. N. Johnson
ARCHIVES OF DISEASE IN CHILDHOOD (2008)
Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial
K. J. S. Anand et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
IV acetaminophen pharmacokinetics in neonates after multiple doses
G. M. Palmer et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions
Simon N. Muchohi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Facilitation of drug evaluation in children by population methods and modelling
Michel Tod et al.
CLINICAL PHARMACOKINETICS (2008)
Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery
Sandra A. Prins et al.
PEDIATRIC ANESTHESIA (2008)
Postmenstrual age and CYP2D6 polymorphisms determine tramadol O-demethylation in critically I11 neonates and infants
Karel Allegaert et al.
PEDIATRIC RESEARCH (2008)
Maturational pharmacokinetics of single intravenous bolus of propofol
Karel Allegaert et al.
PEDIATRIC ANESTHESIA (2007)
Prediction of drug clearance in children: Impact of allometric exponents, body weight, and age
Iftekhar Mahmood
THERAPEUTIC DRUG MONITORING (2007)
Allometric exponents do not support a universal metabolic allometry
Craig R. White et al.
ECOLOGY (2007)
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
Karl Brendel et al.
PHARMACEUTICAL RESEARCH (2006)
Prediction of drug clearance in children from adults: a comparison of several allometric methods
I Mahmood
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery
MYM Peeters et al.
ANESTHESIOLOGY (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Beyond the '3/4-power law': variation in the intra- and interspecific scaling of metabolic rate in animals
DS Glazier
BIOLOGICAL REVIEWS (2005)
Population pharmacokinetic studies in pediatrics: Issues in design and analysis
B Meibohm et al.
AAPS JOURNAL (2005)
A literature review on off-label drug use in children
C Pandolfini et al.
EUROPEAN JOURNAL OF PEDIATRICS (2005)
Re-examination of the '3/4-law of metabolism
PS Dodds et al.
JOURNAL OF THEORETICAL BIOLOGY (2001)
Share Paper
